Winclove Probiotics

Winclove Probiotics, established in Amsterdam, has been specializing in research, development and manufacturing of probiotic formulations since 1987. In close collaboration with business partners, research institutes and university hospitals we develop evidence-based, indication-specific probiotics for a variety of indications. Our probiotic formulations enable people worldwide to improve their health in a natural way.

Our PrOud study has been nominated for the Dutch James Lind Innovation Award!

05/26/2021

We are proud to inform you that our PrOud study has been nominated for the Dutch James Lind Innovation Award! This innovation award is initiated by the NPN, the Dutch industry association. The...

Press release: Winclove Probiotics earns B Corp Certification

03/09/2021

Winclove Probiotics was honored to receive the coveted B Corp Certification last November. Only companies that demonstrably and continuously strive for a healthy society, a healthy economy and a...

Metabolic Health

Recent research has indicated that the gut microbiota plays an important role in managing metabolic health. Learn more about the potential role of Probiotics in Metabolic Health.

NOVOBIOME; platform for NGP product development

12/23/2020

Winclove Probiotics together with academic and industrial partners is developing the NOVOBIOME platform.

How to define superior quality standards for probiotics

09/15/2020

A manuscript developed in collaboration with Institute AllergoSan and published in the peer reviewed journal Nutrients

Business Opportunities

Winclove’s mission is to create long-lasting, sustainable and strategic partnerships with customers and to provide them with the distinct competitive advantages that help them succeed in the market

Science Center

Research is the foundation of our probiotic formulations. We have over 25 years of experience in researching, developing, and producing probiotic formulations in collaboration with top research institutes, universities and academic hospitals.

Our PrOud study has been nominated for the Dutch James Lind Innovation Award!

05/26/2021

We are proud to inform you that our PrOud study has been nominated for the Dutch James Lind

Study Results: Pragmatic evaluation of the implementation of probiotics in elderly care (prOud)

05/26/2021

Implementation of probiotics for elderly people, especially those in care institutes, opens new horizons for probiotics use.

Research on gut microbiota and autism

04/06/2021

Last Friday, April the 2nd 2021, was World Autism Awareness Day. Autism, or Autism Spectrum Disorder (ASD), has many subtypes and refers to a broad range of conditions characterized by challenges with social skills, repetitive behaviors, speech, and nonverbal communication. Currently, there is no medical detection or cure for ASD.